Cited by 19Neurological Disorders and TreatmentsNeuroinflammation and Neurodegeneration MechanismsTraumatic Brain Injury and Neurovascular Disturbances

Therapeutic effects of polydeoxyribonucleotide in an in vitro neuronal model of ischemia/reperfusion injury

Open access
Jo, Seongmoon, Baek, Ahreum, Cho, Yoonhee, Kim, Sung Hoon, Baek, Dawoon, Hwang, Jihye, Cho, Sung-Rae, Kim, Hyun Jung·2023·Scientific Reports

Abstract

Polydeoxyribonucleotide (PDRN) is an agonist that selectively stimulates adenosine A 2A receptor (ADORA2A), which suppresses inflammatory responses. Ischemia/reperfusion (I/R) injury plays a major role in the pathogenesis of ischemic stroke by inducing neuroinflammation. Therefore, this study aimed to investigate the therapeutic effects of PDRN in an in vitro I/R injury model. The in vitro model was established with differentiated Neuro-2a cells under oxygen and glucose deprivation condition. The cells were treated with PDRN for 24 h under reoxygenation condition. As the results of RNA-seq transcriptome analysis, CSF1, IL-6, PTPN6, RAC2, and STAT1 were identified of its relation to the effect of PDRN on inflammatory responses in the model. To further investigate therapeutic effects of PDRN, RT-qPCR, western blotting, LDH assay, and TUNEL assay were performed. PDRN significantly reversed the expression of genes and proteins related to inflammatory responses. The elevated ADORA2A expression by PDRN treatment downregulated JAK/STAT pathway in the model. Furthermore, PDRN inhibited neuronal cell death in the model. Consequently, our results suggested that PDRN alleviated inflammatory responses through inhibition of JAK/STAT pathway by mediating ADORA2A expression and inhibited neuronal cell death in the model. These results provide significant insights into potential therapeutic approaches involving PDRN treatment for I/R injury.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-023-32744-9

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PDRNs are classified as prescription medications approved for injectable use for wound healing/tissue repair and knee osteoarthritis.

    “PDRNs are classified as prescription medications approved for injectable use for wound healing/tissue repair and knee osteoarthritis [19,173,174].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [174]

    The Results section describes PDRN as a drug used to treat osteoarthritis, and the References list studies of wound healing and intra-articular injections for knee osteoarthritis (no page numbers available). The paper does not say PDRNs are classified as prescription medications or approved for injectable use for either indication. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Jo, S., Baek, A., Cho, Y., Kim, S. H., Baek, D., Hwang, J., Cho, S.-R., & Kim, H. J.
Affiliations
  • Yonsei University (KR)
  • Eulji University (KR)
Corresponding author
  • Kim, Sung Hoon
  • Cho, Sung-Rae
  • Kim, Hyun Jung
Venue
Scientific Reports
Published
2023-04-12
Volume
13
Issue
1
Pages
6004-6004
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4365151359
Cited by
19
References
34
Citations by year
2026: 6 · 2025: 8 · 2024: 5
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Hyundai Motor Chung Mong-Koo Foundation
  • National Research Foundation, South Korea (NRF-2022R1A2C1006374)
  • Student Research Bursary of Yonsei University College of Medicine (2020)
  • Korean Fund for Regenerative Medicine (21A0202L1, 21C0715L1)
  • Korea Health Industry Development Institute (HI21C1314, HI22C1588)
  • Eulji University (2020)
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
polydeoxyribonucleotide, ischemia-reperfusion injury, neuroinflammation, adenosine A2A receptor, JAK/STAT signaling, neuronal cell death, ischemic stroke, oxygen-glucose deprivation, N2a cells, CSF-1, interleukin-6, STAT1, SHP-1, Rac2
MeSH terms
Humans, Ischemia, Polydeoxyribonucleotides, Signal Transduction, Reperfusion Injury, STAT Transcription Factors, Janus Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review